Cardioprotective role of G-Protein Coupled Estrogen Receptor 1 (GPER1)

References

• Barchiesi F, Lucchinetti E, Zaugg M, Ogunshola OO, Wright M, Meyer M, et al. 2010. Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection. Hypertension 56:964–972
   PubMed Web of Science ®Google Scholar
• Bopassa JC, Eghbali M, Toro L, Stefani E. 2010. A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 298:H16–23
   PubMed Web of Science ®Google Scholar
• Chakrabarti S, Davidge ST. 2012. G-protein coupled receptor 30 (GPR30): A novel regulator of endothelial inflammation. PLoS One 7:e52357
   PubMed Web of Science ®Google Scholar
• Davis KE, Carstens EJ, Irani BG, Gent LM, Hahner LM, Clegg DJ. 2014. Sexually dimorphic role of G protein-coupled estrogen receptor (GPER) in modulating energy homeostasis. Horm Behav 66:196–207
   PubMed Web of Science ®Google Scholar
• Deschamps AM, Murphy E, Sun J. 2010. Estrogen receptor activation and cardioprotection in ischemia reperfusion injury. Trends Cardiovasc Med 20:73–78
   PubMed Web of Science ®Google Scholar
• do Nascimento GR, Barros YV, Wells AK, Khalil RA. 2009. Research into specific modulators of vascular sex hormone receptors in the management of postmenopausal cardiovascular disease. Curr Hypertens Rev 5:283–306
   PubMedGoogle Scholar
• Dubey RK, Jackson EK, Keller PJ, Imthurn B, Rosselli M. 2001. Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism. Hypertension 37:640–644
   PubMed Web of Science ®Google Scholar
• Filardo EJ, Quinn JA, Bland KI, Frackelton AR Jr. 2000. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 14:1649–1660
   PubMed Web of Science ®Google Scholar
• Filardo EJ, Thomas P. 2012. Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. Endocrinology 153:2953–2962
   PubMed Web of Science ®Google Scholar
• Iwasa M, Yamada Y, Kobayashi H, Yasuda S, Kawamura I, Sumi S, et al. 2011. Both stimulation of GLP-1 receptors and inhibition of glycogenolysis additively contribute to a protective effect of oral miglitol against ischaemia-reperfusion injury in rabbits. Br J Pharmacol 164:119–131
   PubMed Web of Science ®Google Scholar
• Koganti S, Snyder R, Gumaste U, Karamyan VT, Thekkumkara T. 2014. 2-methoxyestradiol binding of GPR30 down-regulates angiotensin AT(1) receptor. Eur J Pharmacol 723:131–140
   PubMed Web of Science ®Google Scholar
• LaVallee TM, Zhan XH, Herbstritt CJ, Kough EC, Green SJ, Pribluda VS. 2002. 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res 62:3691–3697
   PubMed Web of Science ®Google Scholar
• Li ZL, Liu JC, Liu SB, Li XQ, Yi DH, Zhao MG. 2012. Improvement of vascular function by acute and chronic treatment with the GPR30 agonist G1 in experimental diabetes mellitus. PLoS One 7:e38787
   PubMed Web of Science ®Google Scholar
• Prossnitz ER, Barton M. 2014. Estrogen biology: new insights into GPER function and clinical opportunities. Mol Cell Endocrinol 389:71–83
   PubMed Web of Science ®Google Scholar
• Pupo M, Vivacqua A, Perrotta I, Pisano A, Aquila S, Abonante S, et al. 2013. The nuclear localization signal is required for nuclear GPER translocation and function in breast Cancer-Associated Fibroblasts (CAFs). Mol Cell Endocrinol 376:23–32
   PubMed Web of Science ®Google Scholar
• Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER. 2005. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625–1630
   PubMed Web of Science ®Google Scholar
• Seok YM, Jang EJ, Reiser O, Hager M, Kim IK. 2012. 17beta-Estradiol induces vasorelaxation in a G-protein-coupled receptor 30-independent manner. Naunyn Schmiedebergs Arch Pharmacol 385:945–948
   PubMed Web of Science ®Google Scholar
• Sessa R, Pietro MD, Filardo S, Turriziani O. 2014. Infectious burden and atherosclerosis: A clinical issue. World J Clin Cases 2:240–249
   PubMedGoogle Scholar
• Zhang Y, Yang X, Bian F, Wu P, Xing S, Xu G, et al. 2014. TNF-alpha promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells: crosstalk between NF-kappaB and PPAR-gamma. J Mol Cell Cardiol 72:85–94
   PubMed Web of Science ®Google Scholar